DOFETILIDE ASSOCIATED QT PROLONGATION: ACTUAL VERSUS IDEAL BODY WEIGHT TO CALCULATE DOSING
| Autor: | Stephen Wang, Robert W Maloney, Terrence D. Welch, Rajbir S. Sangha, Aaron V. Kaplan |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
business.industry
Dofetilide Atrial fibrillation urologic and male genital diseases Body weight medicine.disease QT interval female genital diseases and pregnancy complications Discontinuation Anesthesia Medicine Dose reduction Dosing Cardiology and Cardiovascular Medicine business reproductive and urinary physiology medicine.drug |
| Zdroj: | Journal of the American College of Cardiology. 69:401 |
| ISSN: | 0735-1097 |
| Popis: | Background: Dofetilide is used to treat patients with atrial fibrillation, with recommended dosing based on the Cockcroft-Gault formula using actual body weight (ABW). Dose reduction or discontinuation may be necessary for excessive QT prolongation. We investigated whether initial dosing based on |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|